Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Inbentus
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== <vimeo>490773178</vimeo> Thousands of people die every day from a lack of medical respirators. These high-reliability devices are inaccessible to emerging markets due to their expense. COVID has made this problem worse. Established at the beginning of 2020, we want to make respirators more accessible to less affluent populations. That's why we started INBENTUS. In less than 1 month we've developed a COVID emergency respirator prototype that's competitively priced with the first units having been delivered to Latin American countries already. Although our initial strategy is focused on COVID patients, several international studies indicate that respiratory pathologies will be a huge global problem over the next 20 years, due to: * Increases in world population by almost 30%. * Increases in life expectancy. By 2027, β¬12bn+ euros are expected to be spent on respiratory medical technology which has sustained annual growth of 16%. To meet this strong demand, we plan to start developing a new & improved high-performance respirator that's more inexpensive with the aim to achieve high penetration in Latin America & Africa in the coming years. Hospitals of public & private health networks are our main targets to obtain revenue. Funds will be used to boost sales and complete authorization of our existing respirator, launch local campaigns in target countries and to develop our new, high-performance respirator product.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)